Resultados de la búsqueda 371-380 of 10748 for polycystic ovary syndrome
... ovarian cancer, (7) advanced, unresectable clear ... disease following an attempt to perform ... disease. Numeración de páginas Estudios clínicos.
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. ... ovarian cancer, (7) advanced, ...
... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...
These phone numbers will connect you directly with an appointment coordinator in Referring Physician Services at the respective Mayo Clinic campus. Patient ...
... disease). This is an investigational study. Radiation therapy is delivered ... disease, or symptomatic radiation brain necrosis in patients with brain ...
... disease with complete and long-term clinical follow-up to identify those who developed breast cancer (cases) and those who did not (controls); the ...
... ovarian cancer, (7) advanced, unresectable clear ... disease following an attempt to perform ... disease. Determinants of Incident Stroke Cognitive ...
Science Saturday: Confronting polycystic kidney disease, a silent killer Aug. 12, 2023, 11:00 a.m. CDT. Productos y servicios. Boletín informativo: Mayo ...
... disease progression and treatment response. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?